Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS3 | P29474 | 2/20 | 0.50 |
| ▸ | NOS1 | P29475 | 2/20 | 0.50 |
| ▸ | NOS2 | P35228 | 2/20 | 0.50 |
| ▸ | PKM | P14618 | 2/20 | 0.50 |
| ▸ | PNMT | P11086 | 1/20 | 0.50 |
| ▸ | ALPI | P09923 | 1/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.50 |
| ▸ | XIAP | P98170 | 1/20 | 0.50 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 2/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | BLM | P54132 | 2/20 | 0.46 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | RGS12 | O14924 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17653888 | 1.00 | NOS3 (0.50) | NOS3NOS1NOS2PKMPNMT | |
| SCHEMBL29168278 | 1.00 | NOS3 (0.50) | NOS3NOS1NOS2PKMPNMT | |
| SCHEMBL30013884 | 1.00 | NOS3 (0.50) | NOS3NOS1NOS2PKMPNMT | |
| Hydrochloric Acid SCHEMBL29168207 | 0.98 | NOS3 (0.49) | NOS3NOS1NOS2PKMPNMT | |
| SCHEMBL30962394 | 0.86 | PNMT (0.50) | NOS3NOS1NOS2PNMTKDM4E | |
| SCHEMBL29351556 | 0.86 | PKM (0.58) | NOS3NOS1NOS2PKMALPI | |
| SCHEMBL43976 | 0.86 | PKM (0.58) | NOS3NOS1NOS2PKMALPI | |
| SCHEMBL298903 | 0.86 | PKM (0.58) | NOS3NOS1NOS2PKMALPI | |
| SCHEMBL35491891 | 0.86 | PKM (0.58) | NOS3NOS1NOS2PKMALPI | |
| SCHEMBL43977 | 0.86 | PKM (0.58) | NOS3NOS1NOS2PKMALPI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 156 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117405800-A | Method for simultaneously detecting reduced biological ammonia sulfhydryl compound and oxidized biological ammonia sulfhydryl compound | 上海中医药大学 | 2024-01-16 | — | — | CN | claimed |
| CN-116678974-A | Screening method of Alzheimer disease plasma metabolism marker, plasma metabolism marker and application | 上海大学 | 2023-09-01 | — | — | CN | claimed |
| EP-3149029-B1 | LIPIDATED PEPTIDES AS NEUROPROTECTIVE AGENTS | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR V V I (CZ) | 2019-06-19 | — | — | EP | claimed |
| CN-109709235-A | Early diagnosis, prediction biomarker combinations, application and its measuring method of Alzheimer disease or slight old cognitive disorder | 马红华 | 2019-05-03 | — | — | CN | claimed |
| EP-3094643-B1 | LIPIDATED PEPTIDES FOR LOWERING BLOOD GLUCOSE | FYZIOLOGICKY USTAV AKADEMIE VED CESKE REPUBLIKY V V I (CZ) | 2018-10-17 | — | — | EP | claimed |
| EP-3157948-A1 | LONG-ACTING STABLE PEPTIDE GHRELIN ANALOGS FOR THE TREATMENT OF CACHEXIA | Ustav Organicke Chemie A Biochemie Av Cr, V.v.i. (CZ) | 2017-04-26 | — | — | EP | claimed |
| EP-3149029-A1 | LIPIDATED PEPTIDES AS NEUROPROTECTIVE AGENTS | Ustav Organicke Chemie A Biochemie Av Cr, V.v.i. (CZ) | 2017-04-05 | — | — | EP | claimed |
| US-20170051031-A1 | LIPIDATED PEPTIDES AS NEUROPROTECTIVE AGENTS | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V.V.I. (CZ) | 2017-02-23 | — | — | US | claimed |
| US-20170044230-A1 | LONG-ACTING STABLE PEPTIDE GHRELIN ANALOGS FOR THE TREATMENT OF CACHEXIA | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V.V.I. (CZ) | 2017-02-16 | — | — | US | claimed |
| EP-3094643-A2 | LIPIDATED PEPTIDES FOR LOWERING BLOOD GLUCOSE | Fyziologicky Ústav Akademie VED Ceské Republiky, V.V.I. (CZ) | 2016-11-23 | — | — | EP | claimed |
| WO-2003059394-A2 | COMPOSITION FOR TRANSPORTING OLIGONUCLEOTIDES THROUGH THE BLOOD BRAIN BARRIER AND THEIR USE FOR TREATING CENTRAL NERVOUS SYSTEM DISEASES | SYNT:EM (FR) | 2003-07-24 | — | — | WO | claimed |
| WO-2003026701-A1 | TRANSPORTING OF TAXOID DERIVATIVES THROUGH THE BLOOD BRAIN BARRIER | SYNT:EM (FR) | 2003-04-03 | — | — | WO | claimed |
| WO-2003026700-A2 | COMPOSITIONS FOR TRANSPORTING ANTIBODIES THROUGH THE BLOOD BRAIN BARRIER AND THEIR USE FOR DIAGNOSING OR TREATING CENTRAL NERVOUS SYSTEM DISEASES | SYNT:EM (FR) | 2003-04-03 | — | — | WO | claimed |
| EP-1135168-A1 | PEPTIDES CARRYING SUBSTANCES ACROSS THE BLOOD BRAIN BARRIER | Synt:em (S.A.) (FR) | 2001-09-26 | — | — | EP | claimed |
| EP-1135169-A1 | PHARMACEUTICAL COMPOSITION COMPRISING AN ANTI-CANCER AGENT AND AT LEAST A PEPTIDE | Synt:em (S.A.) (FR) | 2001-09-26 | — | — | EP | claimed |
| EP-1084137-A1 | PEPTIDE INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE | ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A. (IT) | 2001-03-21 | — | — | EP | claimed |
| WO-2000032236-A1 | PEPTIDES CARRYING SUBSTANCES ACROSS THE BLOOD BRAIN BARRIER | SYNT:EM (S.A.) (FR) | 2000-06-08 | — | — | WO | claimed |
| WO-2000032237-A1 | PHARMACEUTICAL COMPOSITION COMPRISING AN ANTI-CANCER AGENT AND AT LEAST A PEPTIDE | SYNT:EM (S.A.) (FR) | 2000-06-08 | — | — | WO | claimed |
| WO-1999064442-A1 | PEPTIDE INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE | ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P ANGELETTI S.P.A. (IT) | 1999-12-16 | — | — | WO | claimed |
| US-5352666-A | Using a renin inhibitor | SCHERING CORPORATION (US) | 1994-10-04 | — | — | US | claimed |